(c) 2024 PillSync.com

nabumetone 500 MG Oral Tablet

INDICATIONS AND USAGE Carefully consider the potential benefits and risks of nabumetone tablets, USP and other treatment options before deciding to use nabumetone tablets, USP. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Nabumetone tablets, USP are indicated: • For relief of the signs and symptoms of rheumatoid arthritis. • For relief of the signs and symptoms of osteoarthritis.

Eon Labs, Inc.


43 minutes ago OVAL WHITE E145 nabumetone 500 MG Oral Tablet

OVAL WHITE E145

43 minutes ago OVAL WHITE E145 nabumetone 500 MG Oral Tablet

E145 OVAL WHITE

HOW SUPPLIED Nabumetone Tablets, USP, for oral administration, are available as 500 mg oval-shaped, white film coated tablets, debossed “ E 145" on one side, plain on the other side and supplied as: NDC 0185-0145-01 bottles of 100 NDC 0185-0145-05 bottles of 500 750 mg oval-shaped, white film coated tablets, debossed “ E 146" on one side, plain on the other side and supplied as: NDC 0185-0146-01 bottles of 100 NDC 0185-0146-05 bottles of 500 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Dispense contents in a tight, light-resistant container as defined in the USP with a child-resistant closure, as required. KEEP TIGHTLY CLOSED.


More pills like OVAL E145












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site